Radiologic  ||| S:0 E:11 ||| JJ
features  ||| S:11 E:20 ||| NNS
of  ||| S:20 E:23 ||| IN
pancreatic  ||| S:23 E:34 ||| NN
and  ||| S:34 E:38 ||| CC
biliary  ||| S:38 E:46 ||| JJ
complications  ||| S:46 E:60 ||| NNS
following  ||| S:60 E:70 ||| VBG
composite  ||| S:70 E:80 ||| JJ
visceral  ||| S:80 E:89 ||| NNS
transplantation  ||| S:89 E:105 ||| VBP
Small  ||| S:105 E:111 ||| JJ
bowel  ||| S:111 E:117 ||| JJ
transplantation  ||| S:117 E:133 ||| NN
is  ||| S:133 E:136 ||| VBZ
a  ||| S:136 E:138 ||| DT
surgical  ||| S:138 E:147 ||| JJ
technique  ||| S:147 E:157 ||| NN
reserved  ||| S:157 E:166 ||| VBN
for  ||| S:166 E:170 ||| IN
patients  ||| S:170 E:179 ||| NNS
with  ||| S:179 E:184 ||| IN
end-stage  ||| S:184 E:194 ||| JJ
intestinal  ||| S:194 E:205 ||| JJ
failure ||| S:205 E:212 ||| NN
.  ||| S:212 E:214 ||| .
Despite  ||| S:214 E:222 ||| IN
its  ||| S:222 E:226 ||| PRP$
inherent  ||| S:226 E:235 ||| JJ
technical  ||| S:235 E:245 ||| JJ
difficulties ||| S:245 E:257 ||| NNS
,  ||| S:257 E:259 ||| ,
it  ||| S:259 E:262 ||| PRP
has  ||| S:262 E:266 ||| VBZ
emerged  ||| S:266 E:274 ||| VBN
as  ||| S:274 E:277 ||| IN
the  ||| S:277 E:281 ||| DT
standard  ||| S:281 E:290 ||| NN
of  ||| S:290 E:293 ||| IN
care  ||| S:293 E:298 ||| NN
for  ||| S:298 E:302 ||| IN
these  ||| S:302 E:308 ||| DT
patients ||| S:308 E:316 ||| NNS
.  ||| S:316 E:318 ||| .
This  ||| S:318 E:323 ||| DT
article  ||| S:323 E:331 ||| NN
reviews  ||| S:331 E:339 ||| VBZ
the  ||| S:339 E:343 ||| DT
background  ||| S:343 E:354 ||| NN
and  ||| S:354 E:358 ||| CC
different  ||| S:358 E:368 ||| JJ
surgical  ||| S:368 E:377 ||| JJ
techniques  ||| S:377 E:388 ||| NNS
for  ||| S:388 E:392 ||| IN
this  ||| S:392 E:397 ||| DT
procedure  ||| S:397 E:407 ||| NN
and  ||| S:407 E:411 ||| CC
then  ||| S:411 E:416 ||| RB
fully  ||| S:416 E:422 ||| RB
describes  ||| S:422 E:432 ||| VBZ
the  ||| S:432 E:436 ||| DT
spectrum  ||| S:436 E:445 ||| NN
of  ||| S:445 E:448 ||| IN
imaging  ||| S:448 E:456 ||| JJ
findings  ||| S:456 E:465 ||| NNS
of  ||| S:465 E:468 ||| IN
pancreatic  ||| S:468 E:479 ||| NN
and  ||| S:479 E:483 ||| CC
biliary  ||| S:483 E:491 ||| JJ
complications ||| S:491 E:504 ||| NNS
,  ||| S:504 E:506 ||| ,
which  ||| S:506 E:512 ||| WDT
have  ||| S:512 E:517 ||| VBP
a  ||| S:517 E:519 ||| DT
prevalence  ||| S:519 E:530 ||| NN
of  ||| S:530 E:533 ||| IN
up  ||| S:533 E:536 ||| RB
to  ||| S:536 E:539 ||| TO
17 ||| S:539 E:541 ||| CD
% ||| S:541 E:542 ||| NN
,  ||| S:542 E:544 ||| ,
after  ||| S:544 E:550 ||| IN
this  ||| S:550 E:555 ||| DT
procedure  ||| S:555 E:565 ||| NN
based  ||| S:565 E:571 ||| VBN
on  ||| S:571 E:574 ||| IN
23-year  ||| S:574 E:582 ||| CD
single-center  ||| S:582 E:596 ||| JJ
experience ||| S:596 E:606 ||| NN
.  ||| S:606 E:608 ||| .
The  ||| S:608 E:612 ||| DT
pancreaticobiliary  ||| S:612 E:631 ||| JJ
complications  ||| S:631 E:645 ||| NNS
encountered  ||| S:645 E:657 ||| VBD
in  ||| S:657 E:660 ||| IN
our  ||| S:660 E:664 ||| PRP$
experience  ||| S:664 E:675 ||| NN
and  ||| S:675 E:679 ||| CC
discussed  ||| S:679 E:689 ||| VBN
in  ||| S:689 E:692 ||| IN
this  ||| S:692 E:697 ||| DT
article  ||| S:697 E:705 ||| NN
include ||| S:705 E:712 ||| VBP
:  ||| S:712 E:714 ||| :
ampullary  ||| S:714 E:724 ||| JJ
stenosis ||| S:724 E:732 ||| NN
,  ||| S:732 E:734 ||| ,
biliary  ||| S:734 E:742 ||| JJ
cast ||| S:742 E:746 ||| NN
,  ||| S:746 E:748 ||| ,
choledocholithiasis ||| S:748 E:767 ||| NN
,  ||| S:767 E:769 ||| ,
bile  ||| S:769 E:774 ||| JJ
leak ||| S:774 E:778 ||| NN
,  ||| S:778 E:780 ||| ,
recurrent  ||| S:780 E:790 ||| JJ
cholangitis ||| S:790 E:801 ||| NN
,  ||| S:801 E:803 ||| ,
acute  ||| S:803 E:809 ||| JJ
pancreatitis ||| S:809 E:821 ||| NN
,  ||| S:821 E:823 ||| ,
chronic  ||| S:823 E:831 ||| JJ
pancreatitis ||| S:831 E:843 ||| NN
,  ||| S:843 E:845 ||| ,
and  ||| S:845 E:849 ||| CC
pancreatic  ||| S:849 E:860 ||| JJ
duct  ||| S:860 E:865 ||| JJ
fistula ||| S:865 E:872 ||| NN
.  ||| S:872 E:874 ||| .
Familiarity  ||| S:874 E:886 ||| NNP
with  ||| S:886 E:891 ||| IN
the  ||| S:891 E:895 ||| DT
broad  ||| S:895 E:901 ||| JJ
spectrum  ||| S:901 E:910 ||| NN
of  ||| S:910 E:913 ||| IN
PB  ||| S:913 E:916 ||| NNP
complications  ||| S:916 E:930 ||| NNS
and  ||| S:930 E:934 ||| CC
their  ||| S:934 E:940 ||| PRP$
variable  ||| S:940 E:949 ||| JJ
manifestations  ||| S:949 E:964 ||| NNS
will  ||| S:964 E:969 ||| MD
help  ||| S:969 E:974 ||| VB
radiologists  ||| S:974 E:987 ||| VBN
to  ||| S:987 E:990 ||| TO
accurately  ||| S:990 E:1001 ||| RB
diagnose  ||| S:1001 E:1010 ||| VB
these  ||| S:1010 E:1016 ||| DT
complications  ||| S:1016 E:1030 ||| NNS
which  ||| S:1030 E:1036 ||| WDT
have  ||| S:1036 E:1041 ||| VBP
relatively  ||| S:1041 E:1052 ||| RB
high  ||| S:1052 E:1057 ||| JJ
morbidity  ||| S:1057 E:1067 ||| NN
and  ||| S:1067 E:1071 ||| CC
mortality  ||| S:1071 E:1081 ||| NN
in  ||| S:1081 E:1084 ||| IN
these  ||| S:1084 E:1090 ||| DT
immune-compromised  ||| S:1090 E:1109 ||| JJ
patients ||| S:1109 E:1117 ||| NNS
.  ||| S:1117 E:1119 ||| .
